Authors :
Farmanli Orkhan, Uysal Melike, Ayhan Yunus Emre, Gokdemir Cihan, Donmez Omer Faruk, Bastug Samet, Parlak Murat, Uckun Ilknur, Jafarov Alemdar, Pamuk Ibrahim, Farmanli Kubra, Karatas Ihsan
Volume/Issue :
Volume 5 - 2020, Issue 4 - April
Google Scholar :
https://goo.gl/DF9R4u
Scribd :
https://bit.ly/2wN8IMu
DOI :
10.38124/IJISRT20APR398
The new type of coronavirus, called COVID19, which began to spread all over the world, caused a
pandemic. According to the 24th March data, there is
no cure for this viral acute respiratory disease, which
caused 17,147 deaths. Healthcare professionals use
medications used in previous coronavirus-induced
diseases to relieve symptoms in treatment. Researchers,
on the other hand, evaluate the comparative effects of
these drugs and try to find a new drug or vaccine. We
are publishing a study that biotechnological
combinations of used and non-toxic effective drugs can
be an effective approach to the disease.
